NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.6251
Delayed Data
As of Apr 24
 -0.0049 / -0.78%
Today’s Change
0.42
Today|||52-Week Range
1.30
-0.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues288.0K123.0K152.0K491.0K
 
 
 
 
 
Cost of Goods Sold60.0K18.0K20.0K249.0K
 
 
 
 
 
Depreciation And Amortization70.0K71.0K44.0K47.0K
 
 
 
 
 
 
Operating ExpensesGross Income158.0K34.0K88.0K195.0K
 
 
 
 
 
General Expenses4.2M3.8M4.2M5.1M
 
 
 
 
 
Research And Development2.5M2.2M2.3M2.4M
 
 
 
 
 
Total Operating Expenses4.4M3.9M4.3M5.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.1M-3.8M-4.1M-4.9M
 
 
 
 
 
Extraordinary Credit520.0K797.0K--451.0K
 
 
 
 
Extraordinary Charge-----104.0K0.00
 
 
Other Expenses-7.0K57.0K-2.0K-26.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.6M-2.9M-4.2M-4.5M
 
 
 
 
 
Income Taxes0.00-10.0K0.00-8.0K
 
 
 
Net Income-3.6M-2.9M-4.2M-4.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.3M50.8M50.8M51.5M
 
 
 
 
 
Shares To Calculate EPS Diluted45.3M50.8M50.8M51.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.06-$0.08-$0.09
 
 
 
 
 
EPS Diluted-$0.08-$0.06-$0.08-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account